 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || dabigatran etexilate mesylate oral suspension (WD-1602) - Shanghai Fudan / Zhangjiang, China NT Pharma
New P1 trial: A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa (clinicaltrials.gov) - Oct 18, 2020
P1, N=20, Not yet recruiting, Sponsor: Hong Kong WD Pharmaceutical Co., Limited